News
-
-
PRESS RELEASE
Newron proposes renowned biopharma company founder and entrepreneur Dr. Chris Martin for election as Independent Chairman
Newron Pharmaceuticals S.p.A. proposes Chris Martin, ex-CEO of ADC Therapeutics, as Independent Chairman succeeding Dr. Köstlin after 12 years. Martin an experienced biopharma leader -
-
REGULATED PRESS RELEASE
NFL Biosciences presents the immunological analysis results of its phase 2 CESTO II study confirming the efficacy of NFL-101, its first-in-class treatment for tobacco addiction
NFL Biosciences presents immunological analysis results of phase 2 CESTO II study confirming efficacy of NFL-101 for tobacco addiction. Association between anti-tobacco IgG increase and continuous abstinence strengthens evidence -
-
-
PRESS RELEASE
Publication of Offering Circular relating to the issuance of inaugural Additional Tier 1 securities
Metro Bank Holdings PLC has priced its inaugural £250m 13.875% fixed rate reset perpetual subordinated contingent convertible capital securities to optimize capital structure and support growth -
-
PRESS RELEASE
EQS-Adhoc: Vectron Systems AG: Agreement on Severance and Compensation Payment between Vectron and Shift4 Group under the domination and profit and loss transfer agreement
Vectron Systems AG and Shift4 Group agree on severance and compensation payment under domination and profit transfer agreement, with fixed annual compensation payment set at EUR 0.47 per share -
